The Role of NAD + and NAD + -Boosting Therapies in Inflammatory Response by IL-13.

MLA

Pugel, Anton D., et al. “The Role of NAD + and NAD + -Boosting Therapies in Inflammatory Response by IL-13.” Pharmaceuticals (14248247), vol. 17, no. 2, Feb. 2024, p. 226. EBSCOhost, https://doi.org/10.3390/ph17020226.

APA

Pugel, A. D., Schoenfeld, A. M., Alsaifi, S. Z., Holmes, J. R., & Morrison, B. E. (2024). The Role of NAD + and NAD + -Boosting Therapies in Inflammatory Response by IL-13. Pharmaceuticals (14248247), 17(2), 226. https://doi.org/10.3390/ph17020226

Chicago

Pugel, Anton D., Alyssa M. Schoenfeld, Sara Z. Alsaifi, Jocelyn R. Holmes, and Brad E. Morrison. 2024. “The Role of NAD + and NAD + -Boosting Therapies in Inflammatory Response by IL-13.” Pharmaceuticals (14248247) 17 (2): 226. doi:10.3390/ph17020226.